DTW Operating Expenses

DTE Energy Company 2017 Series E 5.25% Junior Subordinated Debentures due 2077 · Operating Expenses

DTW logo

DTW Operating Expenses

Latest reported$3.96B
DTW TTM Operating Expenses ($2.87B → $3.96B)
High-resolution chart · PNG

DTW operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

DTE Energy Company 2017 Series E 5.25% Junior Subordinated Debentures due 2077 Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
3,963,000,000
4,399,000,000
3,621,000,000
4,087,000,000
2,319,000,000
2,292,000,000
2,247,000,000
2,211,000,000
2,160,000,000
2,122,000,000
2,084,000,000
2,006,000,000
1,981,000,000
1,945,000,000
1,920,000,000
1,911,000,000
1,882,000,000
1,880,000,000
1,841,000,000
1,852,000,000
1,816,000,000
1,831,000,000
1,851,000,000
1,811,000,000
1,819,000,000
1,740,000,000
1,692,000,000
1,663,000,000
1,621,000,000
1,581,000,000
1,556,000,000
1,541,000,000
1,514,000,000
1,493,000,000
1,462,000,000
1,432,000,000
1,399,000,000
1,383,000,000
1,353,000,000
1,389,000,000
1,355,000,000
1,351,000,000
1,322,000,000
1,288,000,000
1,377,000,000
1,410,000,000
1,485,000,000
1,471,000,000
1,457,000,000
1,452,000,000
1,425,000,000
-726,000,000
-753,000,000
-791,000,000
-821,000,000
1,970,000,000
2,634,000,000
3,284,000,000
3,937,000,000
3,938,000,000
3,928,000,000
3,887,000,000
3,903,000,000
3,872,000,000
3,765,000,000
3,733,000,000
3,647,000,000
3,573,000,000
3,619,000,000
3,785,000,000
3,890,000,000
2,070,000,000
2,220,000,000
2,304,000,000
2,347,000,000
4,663,000,000
4,784,000,000
4,848,000,000
5,138,000,000
4,982,000,000
5,060,000,000
5,082,000,000
4,936,000,000
4,679,000,000
4,549,000,000
4,407,000,000
4,250,000,000
4,327,000,000
4,162,000,000
4,131,000,000
4,161,000,000
4,082,000,000
3,978,000,000
3,803,000,000
3,571,000,000
3,394,000,000
3,299,000,000
3,385,000,000
3,202,000,000
3,041,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.